AMRN FY 2019 Earnings — Amarin Corporation plc Revenue & Financial Results | Market Cap Arena

AMRNAmarin Corporation plc

$335M

FY 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$430M+87.5% YoY

Gross Profit

$334M77.7% margin

Operating Income

-$24M-5.6% margin

Net Income

-$23M-5.3% margin

EPS (Diluted)

$-1.32

Cash Flow

Operating Cash Flow

-$9M

Free Cash Flow

-$12M

Stock-Based Comp.

$31M

Balance Sheet

Total Assets

$882M

Total Liabilities

$274M

Stockholders' Equity

$608M

Cash & Equivalents

$645M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$430M	$229M	+87.5%
Gross Profit	$334M	$175M	+91.1%
Operating Income	-$24M	-$108M	+77.6%
Net Income	-$23M	-$116M	+80.6%